Novartis preserves India injunction against 'NOVIETS' mark
Novartis retained an interim injunction against Noviets Pharma after a division bench of the Delhi High Court found a prima facie risk of confusion between their marks, stressing stricter scrutiny for...To view the full article, register now.
Already a subscriber? Click here to view full article